Temozolomide promotes genomic and phenotypic changes in glioblastoma cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Temozolomide promotes genomic and phenotypic changes in glioblastoma cells
Authors
Keywords
Aneuploidy, Chromosome instability, Drug resistance, Glioma, Karyotype, Heterogeneity
Journal
Cancer Cell International
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-05-05
DOI
10.1186/s12935-016-0311-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- mTOR inhibitor temsirolimus and MEK1/2 inhibitor U0126 promote chromosomal instability and cell type-dependent phenotype changes of glioblastoma cells
- (2016) A.A. Stepanenko et al. GENE
- Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment
- (2015) Hinke F. van Thuijl et al. ACTA NEUROPATHOLOGICA
- Pitfalls of the MTT assay: Direct and off-target effects of inhibitors can result in over/underestimation of cell viability
- (2015) A.A. Stepanenko et al. GENE
- Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution
- (2015) Hoon Kim et al. GENOME RESEARCH
- Step-wise and punctuated genome evolution drive phenotype changes of tumor cells
- (2015) Aleksei Stepanenko et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity
- (2015) Mona Meyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-term Temozolomide Treatment Induces Marked Amino Metabolism Modifications and an Increase in TMZ Sensitivity in Hs683 Oligodendroglioma Cells
- (2015) Delphine Lamoral-Theys et al. NEOPLASIA
- Long-term In Vitro Treatment of Human Glioblastoma Cells with Temozolomide Increases Resistance In Vivo through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression
- (2015) Benjamin Le Calvé et al. NEOPLASIA
- Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide
- (2014) Lucio Tentori et al. BMC CANCER
- Treatment of Poorly Differentiated Glioma Using a Combination of Monoclonal Antibodies to Extracellular Connexin-43 Fragment, Temozolomide, and Radiotherapy
- (2014) G. M. Yusubalieva et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy
- (2014) B Auffinger et al. CELL DEATH AND DIFFERENTIATION
- Treatment of glioma by cisplatin-loaded nanogels conjugated with monoclonal antibodies against Cx43 and BSAT1
- (2014) Vladimir P. Baklaushev et al. DRUG DELIVERY
- Karyotypically distinct U251, U373, and SNB19 glioma cell lines are of the same origin but have different drug treatment sensitivities
- (2014) Alexey A. Stepanenko et al. GENE
- MGMT testing—the challenges for biomarker-based glioma treatment
- (2014) Wolfgang Wick et al. Nature Reviews Neurology
- The mTOR signaling pathway as a treatment target for intracranial neoplasms
- (2014) D. Pachow et al. NEURO-ONCOLOGY
- Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolines
- (2014) Joshua C. Anderson et al. RADIOTHERAPY AND ONCOLOGY
- ATM Regulates 3-Methylpurine-DNA Glycosylase and Promotes Therapeutic Resistance to Alkylating Agents
- (2014) S. Agnihotri et al. Cancer Discovery
- Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis
- (2014) Lotte Hiddingh et al. Scientific Reports
- In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies
- (2014) Martina McDermott et al. Frontiers in Oncology
- Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes
- (2013) Daniel Stieber et al. ACTA NEUROPATHOLOGICA
- Temozolomide and Radiotherapy for Newly Diagnosed Glioblastoma Multiforme: A Systematic Review
- (2013) Li-Juan Yang et al. CANCER INVESTIGATION
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Integrative Genomic Analysis of Temozolomide Resistance in Diffuse Large B-Cell Lymphoma
- (2013) V. V. Leshchenko et al. CLINICAL CANCER RESEARCH
- The treatment of glioblastomas: A systematic update on clinical Phase III trials
- (2013) An-an Yin et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Unexpected low-dose toxicity of the universal solvent DMSO
- (2013) Joana Galvao et al. FASEB JOURNAL
- Antagonistic functional duality of cancer genes
- (2013) A.A. Stepanenko et al. GENE
- Response of primary glioblastoma cells to therapy is patient specific and independent of cancer stem cell phenotype
- (2013) Shaun D. Fouse et al. NEURO-ONCOLOGY
- OpenCFU, a New Free and Open-Source Software to Count Cell Colonies and Other Circular Objects
- (2013) Quentin Geissmann PLoS One
- Protective Properties of Radio-Chemoresistant Glioblastoma Stem Cell Clones Are Associated with Metabolic Adaptation to Reduced Glucose Dependence
- (2013) Fei Ye et al. PLoS One
- Temozolomide-modulated glioma proteome: Role of interleukin-1 receptor-associated kinase-4 (IRAK4) in chemosensitivity
- (2013) Durairaj M. Kumar et al. PROTEOMICS
- Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
- (2013) B. E. Johnson et al. SCIENCE
- Personalized treatment strategies in glioblastoma: MGMT promoter methylation status
- (2013) Niklas Thon et al. OncoTargets and Therapy
- Temozolomide and unusual indications: Review of literature
- (2012) Zuzana Tatar et al. CANCER TREATMENT REVIEWS
- Immortalization and malignant transformation of Eukaryotic cells
- (2012) A. A. Stepanenko et al. Cytology and Genetics
- Why imatinib remains an exception of cancer research
- (2012) Steven D. Horne et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells
- (2012) Caroline Happold et al. JOURNAL OF NEUROCHEMISTRY
- Alkylation Sensitivity Screens Reveal a Conserved Cross-species Functionome
- (2012) D. Svilar et al. MOLECULAR CANCER RESEARCH
- STAT3 Inhibition Overcomes Temozolomide Resistance in Glioblastoma by Downregulating MGMT Expression
- (2012) Shinji Kohsaka et al. MOLECULAR CANCER THERAPEUTICS
- Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma
- (2012) Koji Yoshimoto et al. Frontiers in Oncology
- Chromosomal Instability Confers Intrinsic Multidrug Resistance
- (2011) A. J. X. Lee et al. CANCER RESEARCH
- Is carcinogenesis a form of speciation?
- (2011) Peter Duesberg et al. CELL CYCLE
- Bioenergetics Pathways and Therapeutic Resistance in Gliomas: Emerging Role of Mitochondria
- (2011) Corinne E. Griguer et al. CURRENT PHARMACEUTICAL DESIGN
- Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines
- (2011) Stella Sun et al. JOURNAL OF NEURO-ONCOLOGY
- Acquisition of Chemoresistance in Gliomas Is Associated with Increased Mitochondrial Coupling and Decreased ROS Production
- (2011) Claudia R. Oliva et al. PLoS One
- Acquisition of Temozolomide Chemoresistance in Gliomas Leads to Remodeling of Mitochondrial Electron Transport Chain
- (2010) Claudia R. Oliva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance
- (2009) S. Yip et al. CLINICAL CANCER RESEARCH
- Genetic and epigenetic heterogeneity in cancer: A genome-centric perspective
- (2009) Henry H.Q. Heng et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Defining ‘chromosomal instability’
- (2008) Jochen B. Geigl et al. TRENDS IN GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started